(Q58998247)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Axel J Hueber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Renoud J Marijnissen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

9

Leo Joosten

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

7

Mario Zaiss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

11

Jochen Zwerina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Karin Zwerina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Wolfgang Baum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gisela Ruiz Heiland

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Wim van den Berg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Iain McLnnes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Georg Schett

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

20 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

413-423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

The complexities of skeletal biology

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Osteoclasts and the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Mechanisms of Disease: the link between RANKL and arthritic bone disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

TNF-induced structural joint damage is mediated by IL-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Mast cells express IL-17A in rheumatoid arthritis synovium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Treg cells suppress osteoclast formation: a new link between the immune system and bone

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Osteoclasts and arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Dickkopf-1 is a master regulator of joint remodeling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Rheumatic diseases: the effects of inflammation on bone

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

How antirheumatic drugs protect joints from damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

PPAR-gamma regulates osteoclastogenesis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/Fas ligand interaction.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor -independent mouse model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Effect of interleukin 17 on proteoglycan degradation in murine knee joints

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Interleukin-1 is essential for systemic inflammatory bone loss

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Guidelines for assessment of bone microstructure in rodents using micro-computed tomography

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141871

7 January 2021

Identifiers

DOI

10.1002/EJI.201141871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22101928%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference